Little Rock, Ark.-based SCA Pharmaceuticals opened its new manufacturing facility in Windsor Monday morning, where it expects to employ about 361 workers by 2021.
As of Nov. 27, the firm began employing 135 people “with the goal of getting to 150 before the end of the year. Then we’ll be adding significantly in 2018 and 2019,” said Brenden Roche, SCA’s senior marketing coordinator.
In May, SCA announced it would build the new manufacturing plant at 755 Rainbow Road. The company makes injectable pharmaceuticals and pre-filled syringes in ready-to-administer dosages for use at hospitals and healthcare facilities.
SCA Pharmaceuticals already has an $8.5 million loan from the state of Connecticut for the project, and is receiving an undisclosed amount of financial assistance for the 90,000 square-foot manufacturing facility.
The parent facility is regulated by the U.S. Food and Drug Administration and authorized to ship to all 50 states, said Roche. Right now, the Windsor facility is allowed to ship to 19 states, and is hoping to be approved to ship to all 50 states in the coming year, he said.
